Dror Marchaim

4.2k total citations
78 papers, 2.4k citations indexed

About

Dror Marchaim is a scholar working on Molecular Medicine, Epidemiology and Applied Microbiology and Biotechnology. According to data from OpenAlex, Dror Marchaim has authored 78 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Medicine, 27 papers in Epidemiology and 27 papers in Applied Microbiology and Biotechnology. Recurrent topics in Dror Marchaim's work include Antibiotic Resistance in Bacteria (52 papers), Antibiotic Use and Resistance (27 papers) and Bacterial Identification and Susceptibility Testing (22 papers). Dror Marchaim is often cited by papers focused on Antibiotic Resistance in Bacteria (52 papers), Antibiotic Use and Resistance (27 papers) and Bacterial Identification and Susceptibility Testing (22 papers). Dror Marchaim collaborates with scholars based in Israel, United States and Japan. Dror Marchaim's co-authors include Keith S. Kaye, Jason M. Pogue, Yehuda Carmeli, Shiri Navon‐Venezia, Mitchell J. Schwaber, Paul Lephart, Kayoko Hayakawa, Teena Chopra, David Katz and Sandra S. Richter and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Dror Marchaim

75 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dror Marchaim Israel 29 1.6k 716 651 569 540 78 2.4k
Latania K. Logan United States 21 1.6k 1.0× 651 0.9× 478 0.7× 570 1.0× 373 0.7× 66 2.3k
Giannoula S. Tansarli United States 24 1.4k 0.9× 1.0k 1.4× 674 1.0× 828 1.5× 422 0.8× 50 2.5k
Gopi Patel United States 24 1.5k 1.0× 1.1k 1.5× 409 0.6× 653 1.1× 366 0.7× 81 2.7k
Thean Yen Tan Singapore 32 1.3k 0.8× 832 1.2× 516 0.8× 517 0.9× 629 1.2× 104 2.8k
Michael J. Dowzicky United States 33 1.9k 1.2× 609 0.9× 687 1.1× 887 1.6× 747 1.4× 80 2.8k
Samuel K. Bouchillon United States 31 1.9k 1.2× 683 1.0× 825 1.3× 1.1k 1.8× 453 0.8× 51 2.6k
Maria Souli Greece 32 2.5k 1.6× 919 1.3× 773 1.2× 1.2k 2.1× 555 1.0× 71 3.3k
Hyunjoo Pai South Korea 28 1.4k 0.9× 1.1k 1.5× 376 0.6× 434 0.8× 225 0.4× 116 2.6k
Angela Raffaella Losito Italy 15 1.4k 0.9× 792 1.1× 603 0.9× 729 1.3× 397 0.7× 20 2.1k
Anastasia Antoniadou Greece 34 1.8k 1.2× 1.3k 1.9× 602 0.9× 1.1k 2.0× 426 0.8× 124 3.7k

Countries citing papers authored by Dror Marchaim

Since Specialization
Citations

This map shows the geographic impact of Dror Marchaim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dror Marchaim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dror Marchaim more than expected).

Fields of papers citing papers by Dror Marchaim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dror Marchaim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dror Marchaim. The network helps show where Dror Marchaim may publish in the future.

Co-authorship network of co-authors of Dror Marchaim

This figure shows the co-authorship network connecting the top 25 collaborators of Dror Marchaim. A scholar is included among the top collaborators of Dror Marchaim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dror Marchaim. Dror Marchaim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Edward P., et al.. (2024). The epidemiology of Stenotrophomonas maltophilia and Achromobacter xylosoxidans infections. SHILAP Revista de lepidopterología. 4(1). e18–e18.
2.
3.
Mills, John & Dror Marchaim. (2021). Multidrug-Resistant Gram-Negative Bacteria. Infectious Disease Clinics of North America. 35(4). 969–994. 31 indexed citations
4.
Adler, Amos, David Katz, & Dror Marchaim. (2020). The Continuing Plague of Extended-Spectrum β-Lactamase Producing Enterbacterales Infections. Infectious Disease Clinics of North America. 34(4). 677–708. 15 indexed citations
5.
Mills, John, Keith S. Kaye, Richard B. Evans, et al.. (2020). Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Escherichia Coli Infections in Metro Detroit: Early Dominance of the ST-131 Clone. Infectious Diseases and Therapy. 9(3). 683–690. 4 indexed citations
6.
Zaidenstein, Ronit, et al.. (2020). The impact of improper empirical usage of antipseudomonals on admission to an acute care hospital. Journal of Global Antimicrobial Resistance. 22. 5–8. 4 indexed citations
7.
Ben-David, Debby, et al.. (2020). Antimicrobial use for asymptomatic bacteriuria—First, do no harm. Infection Control and Hospital Epidemiology. 42(1). 37–42. 5 indexed citations
8.
Viau, Roberto, Barry N. Kreiswirth, Mark D. Adams, et al.. (2017). A Comparison of Molecular Typing Methods Applied to Enterobacter cloacae complex: hsp60 Sequencing, Rep-PCR, and MLST.. PubMed Central. 2(1). 23–33. 10 indexed citations
9.
Katz, David, et al.. (2016). Diabetic foot infection in hospitalized adults. Journal of Infection and Chemotherapy. 22(3). 167–173. 20 indexed citations
10.
Lazarovitch, Tsilia, Joseph Coyle, Benjamin Ackerman, et al.. (2015). The Complex Epidemiology of Carbapenem-ResistantEnterobacterInfections: A Multicenter Descriptive Analysis. Infection Control and Hospital Epidemiology. 36(11). 1283–1291. 18 indexed citations
11.
Martin, Emily T., Kayoko Hayakawa, Tsilia Lazarovitch, et al.. (2015). Simple bedside score to optimize the time and the decision to initiate appropriate therapy for carbapenem-resistant Enterobacteriaceae. Annals of Clinical Microbiology and Antimicrobials. 14(1). 31–31. 16 indexed citations
12.
Bhargava, Ashish, Kayoko Hayakawa, Krishna Alluri, et al.. (2014). Risk Factors for Colonization due to Carbapenem-Resistant Enterobacteriaceae among Patients: Exposed to Long-Term Acute Care and Acute Care Facilities. Infection Control and Hospital Epidemiology. 35(4). 398–405. 76 indexed citations
13.
Bogan, Christopher, Keith S. Kaye, Teena Chopra, et al.. (2014). Outcomes of carbapenem-resistant Enterobacteriaceae isolation: Matched analysis. American Journal of Infection Control. 42(6). 612–620. 41 indexed citations
14.
Pogue, Jason M., et al.. (2013). Evaluation of the potential impact of a carbapenem de-escalation program in an academic healthcare system. Journal of Infection and Public Health. 7(1). 50–53. 5 indexed citations
15.
Martin, Emily T., Ryan Tansek, Vicki L. Collins, et al.. (2012). The carbapenem-resistant Enterobacteriaceae score: A bedside score to rule out infection with carbapenem-resistant Enterobacteriaceae among hospitalized patients. American Journal of Infection Control. 41(2). 180–182. 22 indexed citations
16.
Hayakawa, Kayoko, Dror Marchaim, Céline Vidaillac, et al.. (2011). Growing Prevalence of Vancomycin-Resistant Enterococcus faecalis in the Region with the Highest Prevalence of Vancomycin-Resistant Staphylococcus aureus. Infection Control and Hospital Epidemiology. 32(9). 922–924. 16 indexed citations
17.
Marchaim, Dror, Kayoko Hayakawa, Suchitha Bheemreddy, et al.. (2011). Hospital bath basins are frequently contaminated with multidrug-resistant human pathogens. American Journal of Infection Control. 40(6). 562–564. 33 indexed citations
18.
Pogue, Jason M., Dror Marchaim, Donald Kaye, & Keith S. Kaye. (2011). Revisiting “Older” Antimicrobials in the Era of Multidrug Resistance. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(9). 912–921. 38 indexed citations
19.
Marchaim, Dror, Keith S. Kaye, Vance G. Fowler, et al.. (2009). Case–control study to identify factors associated with mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia. Clinical Microbiology and Infection. 16(6). 747–752. 48 indexed citations
20.
Marchaim, Dror, Shiri Navon‐Venezia, Mitchell J. Schwaber, & Yehuda Carmeli. (2008). Isolation of Imipenem-Resistant Enterobacter Species: Emergence of KPC-2 Carbapenemase, Molecular Characterization, Epidemiology, and Outcomes. Antimicrobial Agents and Chemotherapy. 52(4). 1413–1418. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Latania K. Logan Breakdown of academic impact, for papers by Giannoula S. Tansarli Breakdown of academic impact, for papers by Gopi Patel Breakdown of academic impact, for papers by Thean Yen Tan Breakdown of academic impact, for papers by Michael J. Dowzicky Breakdown of academic impact, for papers by Samuel K. Bouchillon Breakdown of academic impact, for papers by Maria Souli Breakdown of academic impact, for papers by Hyunjoo Pai Breakdown of academic impact, for papers by Angela Raffaella Losito Breakdown of academic impact, for papers by Anastasia Antoniadou
Rankless by CCL
2026